Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Facial Fat Transfer Market, by Donor Site
1.4.2 North America Facial Fat Transfer Market, by End Use
1.4.3 North America Facial Fat Transfer Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Facial Fat Transfer Market by Donor Site
3.1 North America Flank Facial Fat Transfer Market by Country
3.2 North America Thigh Facial Fat Transfer Market by Country
3.3 North America Abdomen Facial Fat Transfer Market by Country
Chapter 4. North America Facial Fat Transfer Market by End-Use
4.1 North America Clinics & surgery centers Market by Country
4.2 North America Hospitals Market by Country
Chapter 5. North America Facial Fat Transfer Market by Country
5.1 US Facial Fat Transfer Market
5.1.1 US Facial Fat Transfer Market by Donor Site
5.1.2 US Facial Fat Transfer Market by End-Use
5.2 Canada Facial Fat Transfer Market
5.2.1 Canada Facial Fat Transfer Market by Donor Site
5.2.2 Canada Facial Fat Transfer Market by End-Use
5.3 Mexico Facial Fat Transfer Market
5.3.1 Mexico Facial Fat Transfer Market by Donor Site
5.3.2 Mexico Facial Fat Transfer Market by End-Use
5.4 Rest of North America Facial Fat Transfer Market
5.4.1 Rest of North America Facial Fat Transfer Market by Donor Site
5.4.2 Rest of North America Facial Fat Transfer Market by End-Use
Chapter 6. Company Profiles
6.1 Allergan PLC
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.2 Integra LifeSciences Holdings Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Ipsen Pharma Biotech SAS
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Ranfac Corporation
6.5.1 Company Overview
6.6 Cytori Therapeutics, Inc.
6.6.1 Company Overview
6.7 Suneva Medical, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Partnerships, Collaborations, and Agreements:
6.8 Dr. Korman Laboratories Ltd.
6.8.1 Company Overview
6.9 Scivision Biotech, Inc.
6.9.1 Company Overview
6.1 Teoxane Laboratories SA
6.10.1 Company Overview
Unique Offerings 